{"id":"https://openalex.org/W1519088816","doi":"https://doi.org/10.1002/9780470768594.ch13","title":"Conivaptan (Vaprisol): Vasopressin V1a and V2 Antagonist for Hyponatremia","display_name":"Conivaptan (Vaprisol): Vasopressin V1a and V2 Antagonist for Hyponatremia","publication_year":2010,"publication_date":"2010-07-16","ids":{"openalex":"https://openalex.org/W1519088816","doi":"https://doi.org/10.1002/9780470768594.ch13","mag":"1519088816"},"language":"en","primary_location":{"id":"doi:10.1002/9780470768594.ch13","doi":"https://doi.org/10.1002/9780470768594.ch13","is_oa":false,"landing_page_url":"https://doi.org/10.1002/9780470768594.ch13","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Modern Drug Synthesis","raw_type":"other"},"volume":{"id":"https://openalex.org/W2492537399","display_name":"Modern Drug Synthesis"},"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033094493","display_name":"Brian A. Lanman","orcid":"https://orcid.org/0000-0002-8768-7188","observed_orcids":["https://orcid.org/0000-0002-8768-7188"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Brian A. Lanman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5033094493"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"175","last_page":"190"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11967","display_name":"Electrolyte and hormonal disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11967","display_name":"Electrolyte and hormonal disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10724","display_name":"Ion Transport and Channel Regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/conivaptan","display_name":"conivaptan","score":1.0},{"id":"https://openalex.org/keywords/vasopressin-v2-receptor-antagonist","display_name":"vasopressin V2 receptor antagonist","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hyponatremia","display_name":"hyponatremia","score":0.9890000224113464},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8309999704360962},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9929999709129333},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.9850000143051147},{"id":"https://openalex.org/keywords/drug-synthesis","display_name":"drug synthesis","score":0.6019999980926514},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.6549999713897705}],"concepts":[{"id":"https://openalex.org/C2776703092","wikidata":"https://www.wikidata.org/wiki/Q824292","display_name":"Hyponatremia","level":2,"score":0.7981919646263123},{"id":"https://openalex.org/C2776370428","wikidata":"https://www.wikidata.org/wiki/Q21124841","display_name":"Vasopressin","level":2,"score":0.7081223130226135},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6904894113540649},{"id":"https://openalex.org/C2779881253","wikidata":"https://www.wikidata.org/wiki/Q1587028","display_name":"Vasopressin Antagonists","level":4,"score":0.5952214598655701},{"id":"https://openalex.org/C90474776","wikidata":"https://www.wikidata.org/wiki/Q24784390","display_name":"Vasopressin receptor","level":4,"score":0.4144231677055359},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3573824167251587},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3478734493255615},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3345567584037781},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3045821785926819},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0702035129070282}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/9780470768594.ch13","doi":"https://doi.org/10.1002/9780470768594.ch13","is_oa":false,"landing_page_url":"https://doi.org/10.1002/9780470768594.ch13","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Modern Drug Synthesis","raw_type":"other"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6200000047683716}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1508333662","https://openalex.org/W1907086383","https://openalex.org/W1938462443","https://openalex.org/W1994281033","https://openalex.org/W1994388355","https://openalex.org/W2006683523","https://openalex.org/W2011820327","https://openalex.org/W2013479366","https://openalex.org/W2013927809","https://openalex.org/W2023071165","https://openalex.org/W2025098090","https://openalex.org/W2056420036","https://openalex.org/W2061977229","https://openalex.org/W2063590796","https://openalex.org/W2072266180","https://openalex.org/W2072357817","https://openalex.org/W2082932652","https://openalex.org/W2090301726","https://openalex.org/W2104871844","https://openalex.org/W2110178098","https://openalex.org/W2115690105","https://openalex.org/W2116296294","https://openalex.org/W2118947430","https://openalex.org/W2130722240","https://openalex.org/W2135149679","https://openalex.org/W2141245684","https://openalex.org/W2142120333","https://openalex.org/W2319189417","https://openalex.org/W2395563942","https://openalex.org/W4242997427","https://openalex.org/W4254729059"],"related_works":["https://openalex.org/W4299525638","https://openalex.org/W2240741305","https://openalex.org/W2023071165","https://openalex.org/W2130876454","https://openalex.org/W2014195590","https://openalex.org/W1983541497","https://openalex.org/W2037129842","https://openalex.org/W2115735410","https://openalex.org/W7073742541","https://openalex.org/W1994388355"],"abstract_inverted_index":{"This":[0],"chapter":[1],"contains":[2],"sections":[3],"titled:":[4],"Background":[5],"Pharmacology":[6],"Structure\u2013Activity":[7],"Relationship":[8],"(SAR)":[9],"Pharmacokinetics":[10],"and":[11,15],"Drug":[12],"Metabolism":[13],"Efficacy":[14],"Safety":[16],"Syntheses":[17]},"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-06-24T00:00:00"}